We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MFA Financial, Inc. (MFA) - free report >>
Groupon, Inc. (GRPN) - free report >>
Apellis Pharmaceuticals, Inc. (APLS) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 24th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
MFA Financial, Inc. (MFA - Free Report) : This real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
MFA Financial, Inc. Price and Consensus
MFA Financial, Inc. price-consensus-chart | MFA Financial, Inc. Quote
Griffon Corporation (GFF - Free Report) : This diversified management and holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Griffon Corporation Price and Consensus
Griffon Corporation price-consensus-chart | Griffon Corporation Quote
Office Properties Income Trust (OPI - Free Report) : This national real estate investment trust has seen the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Office Properties Income Trust Price and Consensus
Office Properties Income Trust price-consensus-chart | Office Properties Income Trust Quote
Apellis Pharmaceuticals, Inc. (APLS - Free Report) : This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.
Apellis Pharmaceuticals, Inc. Price and Consensus
Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote
Groupon, Inc. (GRPN - Free Report) : This marketplace which connects consumers to merchants has seen the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.
Groupon, Inc. Price and Consensus
Groupon, Inc. price-consensus-chart | Groupon, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.